N-Terminal Phosphorylation of the Dopamine Transporter Is Required for Amphetamine-Induced Efflux
Open Access
- 16 March 2004
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Biology
- Vol. 2 (3) , e78
- https://doi.org/10.1371/journal.pbio.0020078
Abstract
Amphetamine (AMPH) elicits its behavioral effects by acting on the dopamine (DA) transporter (DAT) to induce DA efflux into the synaptic cleft. We previously demonstrated that a human DAT construct in which the first 22 amino acids were truncated was not phosphorylated by activation of protein kinase C, in contrast to wild-type (WT) DAT, which was phosphorylated. Nonetheless, in all functions tested to date, which include uptake, inhibitor binding, oligomerization, and redistribution away from the cell surface in response to protein kinase C activation, the truncated DAT was indistinguishable from the full-length WT DAT. Here, however, we show that in HEK-293 cells stably expressing an N-terminal-truncated DAT (del-22 DAT), AMPH-induced DA efflux is reduced by approximately 80%, whether measured by superfusion of a population of cells or by amperometry combined with the patch-clamp technique in the whole cell configuration. We further demonstrate in a full-length DAT construct that simultaneous mutation of the five N-terminal serine residues to alanine (S/A) produces the same phenotype as del-22—normal uptake but dramatically impaired efflux. In contrast, simultaneous mutation of these same five serines to aspartate (S/D) to simulate phosphorylation results in normal AMPH-induced DA efflux and uptake. In the S/A background, the single mutation to Asp of residue 7 or residue 12 restored a significant fraction of WT efflux, whereas mutation to Asp of residues 2, 4, or 13 was without significant effect on efflux. We propose that phosphorylation of one or more serines in the N-terminus of human DAT, most likely Ser7 or Ser12, is essential for AMPH-induced DAT-mediated DA efflux. Quite surprisingly, N-terminal phosphorylation shifts DAT from a “reluctant” state to a “willing” state for AMPH-induced DA efflux, without affecting inward transport. These data raise the therapeutic possibility of interfering selectively with AMPH-induced DA efflux without altering physiological DA uptake.Keywords
This publication has 42 references indexed in Scilit:
- The Human Dopamine Transporter Forms a Tetramer in the Plasma MembraneJournal of Biological Chemistry, 2003
- Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomesSynapse, 2003
- Phosphatidylinositol 3-Kinase, Protein Kinase C, and MEK1/2 Kinase Regulation of Dopamine Transporters (DAT) Require N-terminal DAT Phosphoacceptor SitesJournal of Biological Chemistry, 2003
- N-terminal Truncation of the Dopamine Transporter Abolishes Phorbol Ester- and Substance P Receptor-stimulated Phosphorylation without Impairing Transporter InternalizationJournal of Biological Chemistry, 2003
- Dopamine Transporters Are Phosphorylated on N-terminal Serines in Rat StriatumJournal of Biological Chemistry, 2002
- Neurotransmitter Transporters: Recent ProgressAnnual Review of Neuroscience, 1993
- The dopamine hypothesis of the reinforcing properties of cocaineTrends in Neurosciences, 1991
- Diacylglycerol‐Induced Stimulation of Neurotransmitter Release from Rat Brain Striatal SynaptosomesJournal of Neurochemistry, 1990
- Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosisBrain Research Reviews, 1986
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973